Replies to post #231 on Atossa Therapeutics Inc (ATOS)

[rwwine]

I envision this lingering between $4.90 - $5.50 until they report next quarters earnings. Just because a deal was signed with McKesson Medical-Surgical, it doesn't mean ATOS will fly high anytime soon. Sales reps need to be trained and supplied with materials to go out and sell. On the supply side of the equation, the CMO producing the MASCT devices, collection kits, and all the downstream logistics need to be in place. What is important now is simply executing.

I would like to see some type of forward guidance from ATOS on sales estimates for 2014 and margins so we can look at appropriate valuations predicated on meaningful information, not hype.

Please don't get me wrong, I personally would enjoy seeing this valuation much higher a month from now. I'm just working to keep my expectations in check. GLTA